Active, Not Recruiting Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma NCT03224767 Conditions BRAF V600E Mutation Present, Craniopharyngioma, Neoplasms, +5 more Locations University of Alabama at Birmingham Cancer Center — Birmingham, Alabama, United States Sutter Cancer Centers Radiation Oncology Services-Auburn — Auburn, California, United States Alta Bates Summit Medical Center-Herrick Campus — Berkeley, California, United States Mills-Peninsula Medical Center — Burlingame, California, United States View all 106 locations View more locations Show fewer locations Loading locations... View Trial Details
